GenScript Launches eStainTM 2.0 Protein Staining System
May 15, 2011
PISCATAWAY, New Jersey, 3rd May, 2011 Internationally recognized Contract Research Organization (CRO) GenScript USA Incorporation has launched eStainTM 2.0 Protein Staining System to replace the original eStainTM System.
The eStainTM 2.0 System provides fast and convenient protein gel staining in 7 minutes or less and has improved previous version with a totally re-designed, stylish and durable protein staining device (L02016) of extended lifetime. The new system has incorporated a well-designed electric circuit and an optimized control program for increased reliability and reproducibility. Additional features such as a large LCD screen and a waste tray are built in to make the display more clear and simplify the cleanup step respectively. It makes protein gel staining much easier than before, said John Wang, VP of Bio-Reagent Division. I am confident that with this upgrade, our clients will truly enjoy the process of gel staining from now on.
The eStainTM 2.0 System still utilizes eStainTM Protein Staining Pads (R-250, L02011 or G-250, L02012) to complete gel staining as the previous version. A new graphite electrode (L02017) is developed specifically for eStainTM 2.0 Device and for its use only, while the original graphite electrode (L02014) will still be available for the previous version until the end of 2011.
GenScript is a Contract Research Organization (CRO) specialized in biological research and early-phase drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Its headquartered is in Piscataway, New Jersey, where the GenScript is the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.
# # # #
For further information, please contact:
Executive Vice President
GENSCRIPT USA Inc.
Your Innovation Partner in Drug Discovery!